Small Business Innovation Research / Small Business Technology Transfer Phase I, Phase II, Fast-Track Programs SBIR/STTR: Developing Deep Technologies that Advance U.S. Competitiveness and Security ·
HIGH confidence
Researched 2026-07-22 22:47 · profile: researcher
Programme Thesis
The NSF SBIR/STTR program (America's Seed Fund) provides up to $2 million in non-dilutive R&D funding to U.S.-based startups and small businesses to commercialize high-risk, deep technologies that strengthen U.S. competitiveness, drive economic growth, and create jobs. It exists to bridge the gap between federally funded research and marketable products, stimulating private-sector innovation without taking equity or IP.
Selection Criteria
Intellectual Merit: technical innovation, feasibility, and potential to advance scientific knowledge. Broader Impacts: commercial potential, societal benefit, and contribution to U.S. workforce/economic competitiveness. Phase I: technical feasibility and commercial potential (up to $275k, ~6-12 months). Phase II: further development and commercialization readiness (up to $1M, ~24 months). Fast-Track: combined Phase I+II proposal. Reviewers prioritize high-risk/high-reward, clear technical milestones, credible commercialization plan, and strong team. Eligibility: U.S.-owned and operated small business (≤500 employees), principal investigator must be primarily employed by the small business. NSF takes no equity; awardees retain full IP.
Past Winners / Cohort Profiles
Past winners are typically early-stage U.S. deep-tech startups in AI, biotech, advanced manufacturing, quantum, and materials science. Examples include companies like Ekso Bionics (exoskeletons), NanoSonic (nanostructured materials), and many university spinouts. Archetype: a small team (often 2-5 people) with a technical founder, a provisional patent or prototype, and a clear path to a commercial product within 2-3 years. Many winners have prior NSF grants or academic collaborations.
Ideal Candidate Fingerprint
A U.S.-based small business (often a university spinout) with a strong technical founder holding a PhD or equivalent experience, a provisional patent or IP, and a prototype or proof-of-concept. The ideal applicant demonstrates a clear, scalable commercial application of a deep technology, a credible plan for U.S. job creation and economic impact, and a team that includes business or industry expertise alongside technical leadership.
Recommended Framing
Eniola should frame CCT and IMPRINT as a deep-tech platform for addiction liability screening and drug safety, with dual commercial applications: (1) a SaaS tool for pharmaceutical companies to de-risk addiction-prone compounds, and (2) a clinical decision-support tool for prescribers. To qualify, Eniola must partner with a U.S.-based small business (e.g., a U.S. subsidiary of ZYCO or a new co-founded entity) and position himself as the PI with primary employment at that U.S. company. The strong Africa angle can be leveraged as a Broader Impact: addressing the global addiction burden in LMICs, but the proposal must explicitly tie to U.S. economic competitiveness and job creation.
Watch Out
Eniola is not a U.S. citizen or permanent resident, and the SBIR/STTR program requires the PI to be primarily employed by a U.S.-based small business. He is not currently affiliated with a U.S. entity. He has no PhD or formal graduate degree yet (applying for MSc in 2026), which may weaken the 'strong technical team' criterion. The program is highly competitive with a ~10-15% success rate; lack of prior SBIR/STTR experience or U.S. business network is a disadvantage.